Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

649 indexed citations

Abstract

loading...

About

This paper, published in 1990, received 649 indexed citations. Written by Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker, B. J. Kerns, George J. Olt, R. B. Kinney, John T. Soper, R K Dodge and Daniel L. Clarke‐Pearson covering the research area of Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Oncology (421 citations), Molecular Biology (279 citations) and Radiology, Nuclear Medicine and Imaging (275 citations). Published in PubMed.

In The Last Decade

doi.org/w1943712 →

Countries where authors are citing Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Specialization
Citations

This map shows the geographic impact of Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. more than expected).

Fields of papers citing Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w1943712.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026